BLFS · As filed with the SEC

Biolife Solutions balance sheet, by fiscal year

The statement as Biolife Solutions presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Consolidated Balance Sheets · USD thousands

USD thousandsFY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
Assets
Current assets:
Cash and cash equivalents33,03895,38635,40719,44269,86090,4036,448
Restricted cash——313110530
Available-for-sale securities, current portion55,8899,19816,28843,260———
Accounts receivable, trade, net of allowance for credit losses of $22 and $152 as of December 31, 2025 and December 31, 2024, respectively7,9539,16818,65733,93623,2178,0065,345
Inventories30,15529,01343,45634,90428,34511,60210,972
Prepaid expenses and other current assets9,5265,9966,7656,8794,4274,6481,348
Current assets, discontinued operations00—————
Total current assets136,561148,761120,604138,452125,859114,71224,113
Assets held for rent, net———9,0649,8094,7053,922
Assets held for rent, net—6,1037,713————
Property and equipment, net14,7136,08421,07723,63817,65710,1205,572
Operating lease right-of-use assets, net7,46610,67411,44615,29218,7059,6751,040
Financing lease right-of-use assets, net——94272440170
Long-term deposits and other assets—37927328132523050
Other assets3,050——————
Available-for-sale securities, long term31,2504,6285481,332———
Equity Investments———5,0694,3725,8722,500
Equity Investments——5,069————
Equity investments0995—————
Intangible assets, net4,2579,55921,14932,088152,14931,04921,982
Goodwill208,587212,304224,741224,741224,74158,44933,637
Long-term assets, discontinued operations00—————
Total assets405,884399,487412,714450,229554,057234,82992,816
Liabilities and Shareholders’ Equity
Current liabilities:
Accounts payable1,4863,5736,94015,36714,9453,6723,119
Accrued expenses and other current liabilities11,97412,45111,9329,7827,1425,3693,369
Sales taxes payable2,2794,2565,4424,151———
Warranty liability——7,8588,3129,398——
Lease liabilities, operating, current portion2,2431,5112,7972,8602,7581,107804
Lease liabilities, financing, current portion——37615814980
Debt, current portion4,99710,9436,8331,814862——
Warrant liability————02,7800
Contingent consideration, current portion——02,1385,1272,637377
Current liabilities, discontinued operations00—————
Total current liabilities22,97932,73442,17844,58240,38115,5737,669
Warrant liability, long-term—————039,602
Contingent consideration, long-term——02,3184,9004,5151,537
Lease liabilities, operating, long-term10,65712,72313,20514,96216,4668,757550
Lease liabilities, financing, long-term——1,169126291120
Debt, long-term04,99718,31123,7936,353——
Deferred tax liabilities1891241882505,487——
Other long-term liabilities171—010427264
Long-term liabilities, discontinued operations00—————
Total liabilities33,99650,57875,05186,04173,92029,58349,362
Shareholders’ equity:
Preferred stock, $0.001 par value; 1,000,000 shares authorized, Series A, 4,250 shares designated, and 0 shares issued and outstanding as of December 31, 2025 and December 31, 20240000000
Common stock, $0.001 par value; 150,000,000 shares authorized, 48,198,928 and 46,906,765 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively48474543423321
Additional paid-in capital711,404683,939651,305611,739585,397302,598143,485
Accumulated other comprehensive loss, net of taxes13224(345)(679)(282)——
Accumulated deficit(339,696)(335,101)(313,342)(246,915)(105,020)(97,385)(100,052)
Total shareholders’ equity371,888348,909337,663364,188480,137205,24643,454
Total liabilities and shareholders’ equity405,884399,487412,714450,229554,057234,82992,816

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.